<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><!-- InstanceBegin template="/Templates/ContentPage_Standard.dwt" codeOutsideHTMLIsLocked="false" -->

<head>
<!-- InstanceParam name="id" type="text" value="undefined" --><!-- InstanceParam name="class" type="text" value="secondTier" --><!-- InstanceParam name="content" type="boolean" value="true" --><!-- InstanceParam name="optionSpanish" type="boolean" value="false" --><!-- InstanceParam name="optionalFeatures" type="boolean" value="false" --><!-- InstanceParam name="OptionalLocalSearch" type="boolean" value="false" --><!-- InstanceParam name="OptionalLocalA-Z" type="boolean" value="false" --><!-- InstanceParam name="optionalExtra" type="boolean" value="false" --><!-- InstanceParam name="JqueryUI" type="boolean" value="false" --><!-- InstanceParam name="JqueryUiAccordion" type="boolean" value="false" --><!-- InstanceParam name="dojoLibrary" type="boolean" value="false" -->
<meta http-equiv="content-type" content="text/html; charset=utf-8" />
<!-- InstanceBeginEditable name="meta-data" -->
<meta name="Keywords" 		content="HICPAC, 2008 Guideline for Disinfection and Sterilization in Healthcare Facilities, " />
<meta name="DC.Subject" 	content="The Guideline for Disinfection and Sterilization in Healthcare Facilities, 2008, presents evidence-based recommendations on the preferred methods for cleaning, disinfection and sterilization of patient-care medical devices and for cleaning and disinfecting the healthcare environment." />
<meta name="DC.Language" 	scheme="ISO 639-2" content="eng" />
<!-- InstanceEndEditable -->
<meta name="template.version" content="2.5.2" />
<!-- @package: TemplatePackage 'B' @version: "2.5.2" -->
<!-- InstanceBeginEditable name="title-tag" -->
<title>CDC - Disinfection &amp; Sterilization Guideline:Iodophors - HICPAC</title>
<!-- InstanceEndEditable -->
<style type="text/css" media="tv">
empty{color:#000};@import "../../TemplatePackage/css/B/wysiwyg/wysiBaseHome.css"/**/;
</style>
<style type="text/css" media="screen, projection">
@import "../../TemplatePackage/css/B/base-float.css"/**/;
</style>
<script type="text/javascript" src="../../TemplatePackage/js/B/jquery.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/jquery.watermark.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/common.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/startup.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/blocks-ie.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/video.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/navScripts.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/share.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/govdelivery.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/external.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/plugins.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/syndicateThisPage.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/css-include.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/socialMedia.js"></script>

<!-- compliance patch for microsoft browsers -->
<!--[if IE 6]>
<script type="text/javascript" src="/TemplatePackage/js/B/pngfix.js"></script>
<script type="text/javascript" src="/TemplatePackage/js/B/blocks-ie6.js"></script>
<![endif]-->

<!--[if IE 7]>
<link rel="stylesheet" type="text/css" href="/TemplatePackage/css/B/ie7_fixes.css" />
<![endif]-->

<!--[if IE 8]>
<link rel="stylesheet" type="text/css" href="/TemplatePackage/css/B/ie8_fixes.css" />
<![endif]-->

<!--[if lte IE 8]>
<script type="text/javascript" src="/TemplatePackage/js/B/jquery.curvycorners.js"></script>
<![endif]-->
<style type="text/css" media="print">@import "../../TemplatePackage/css/B/print.css";</style>

<link rel="shortcut icon" href="../../TemplatePackage/images/home/favicon.ico" />
<link rel="home" href="../../index.html" title="Home" />

<!-- Begin Survey scripts -->
<script type="text/javascript" src="../../JScript/foresee/foresee-trigger.js"></script>
<script type="text/javascript" src="../../JScript/foresee-variables.js"></script>
<!-- End Survey scripts -->


<!-- Local Topic Styles -->
<!-- InstanceBeginEditable name="local-css" -->
<style type="text/css" media="all">
@import "../local/B/css/local.css"/**/;
</style>
<!--[if IE]>
<script defer language="javascript" type="text/javascript">
		var cdcLeftNav = new CDC.LeftNav("nav-primary");
		cdcLeftNav.render();
</script>
<![endif]-->
<!--[if ! IE]><!-->
<script language="javascript" type="text/javascript">
$().ready(function(){
		
		var cdcLeftNav = new CDC.LeftNav("nav-primary", location.pathname, true, true);
		cdcLeftNav.render();

});
</script>
<!--<![endif]-->

<!-- InstanceEndEditable -->
</head>
<body id="undefined" class="secondTier">

<div id="skipmenu">
	<a href="8_0Iodophors.html#searchBox" class="skippy" title="Skip to search">Skip directly to search</a>
	<a href="8_0Iodophors.html#az" class="skippy" title="Skip to A to Z list">Skip directly to A to Z list</a>
	<a href="8_0Iodophors.html#nav" class="skippy" title="Skip to navigation">Skip directly to navigation</a>
	<a href="8_0Iodophors.html#content-main" class="skippy" title="Skip to content">Skip directly to site content</a>
	<a href="8_0Iodophors.html#content-secondary" class="skippy" title="Skip to page options">Skip directly to page options</a>
</div>
<div id="wrapper">
	<div class="top"></div>
	<div id="wrapper-inner">
		<div id="branding">
			<span id="homeward"><a href="../../index.html" title="Return to the CDC Home Page">CDC Home</a></span>
<div id="branding-logo">
	<div id="branding-logoImage"><img src="../../TemplatePackage/images/cdcHeaderLogo.gif" width="470" height="47" alt="CDC 24/7: Saving Lives. Protecting People.&trade;" border="0" /><a href="../../index.html" title="CDC 24/7: Saving Lives. Protecting People.&trade;"><span>CDC 24/7: Saving Lives. Protecting People.&trade;</span></a></div>
	<div id="searchForm" class="searchResize"><a name="search"></a>
		<form id="searchCDC" method="get" action="https://search.cdc.gov/search">
			<fieldset>
				<div id="cdc-Query">
					<label for="searchBox" class="overlabel search">Search The CDC</label>
					<input id="searchBox" class="searchBox" name="query" maxlength="256" type="text" />
				</div>
				<div id="cdc-Submit">
					<!-- label for="searchButton" class="searchButton">Search Button</label -->
					<input id="searchButton" class="searchButton" src="../../TemplatePackage/images/home/search_button.gif" name="searchButton" alt="Search" type="image" />
					<input name="action" value="search" type="hidden" />
				</div>
				<input type="hidden" name="utf8" value="&#x2713;"/>
				<input type="hidden" name="affiliate" value="cdc-main"/>
			</fieldset>
		</form>
	</div>
</div>
<noscript>
<div class="noscript"> Note: Javascript is disabled or is not supported by your browser. For this reason, some items on this page will be unavailable. For more information about this message, please visit this page: <a href="../../Other/about_cdcgov.html" title="Browser requirements for CDC.gov">About CDC.gov</a>.</div>
</noscript>
<!--<div id="emergency-alert">
<h1></h1> 
<p></p>
<a href="#"></a>
</div>-->
			<div id="topic-title"><!-- InstanceBeginEditable name="topic-title" -->
			<h2><a href="../index.html">Healthcare Infection Control Practices Advisory Committee (HICPAC)</a></h2>
			<!-- InstanceEndEditable -->
			</div>
		</div>
		
		<div id="content">
			<div id="content-inner">
				
				<!-- ########## LEFT NAVIGATION STARTS HERE ########## -->
				<div id="nav-container"><!-- InstanceBeginEditable name="left-nav-include" -->
				<div id="nav">
  <h3><a href="../index.html">HICPAC</a></h3>
	<ul id="nav-primary">
    <li><a href="../about.html">About HICPAC</a></li>
    <li><a href="../roster.html">Member Roster</a></li>
    <li><a href="../charter.html">Charter</a> </li>
    <li><a href="../eCalendar.html">Event Calendar</a>
      <!--ul>
        <li><a href="/hicpac/agenda.html">Meeting Agenda</a></li>  
      </ul-->
    </li>
    <li><a href="../guidelineMethod/guidelineMethod.html">Methodology Guideline</a>
      <ul>
        <li><a href="../guidelineMethod/001_methods_background.html">Background</a></li>
        <li><a href="../guidelineMethod/002_methods_emergingNeeds.html">Strengthening HICPAC Guidelines to Address Emerging Needs</a></li>
        <li><a href="../guidelineMethod/003_methods_Organiz2AccomplishGoals.html">Organizing to Accomplish Our Goals</a> </li>
        <li><a href="../guidelineMethod/004_methods_guidelineDevelopment.html">Methods in Guideline Development</a></li>
        <li><a href="../guidelineMethod/005_methods_challengesOpportunities.html">Looking to Future Challenges and Opportunities</a></li>
        <li><a href="../guidelineMethod/007_methods_References.html">References</a></li>
        <li><a href="../guidelineMethod/008_methods_tables.html">Tables</a></li>
        <li><a href="../guidelineMethod/011_methods_figures.html">Figures</a></li>
      </ul>
    </li>
	<!--li><a href="/hicpac/projects_in_progress.html">Projects in Progress</a></li-->
	<li><a href="../pubs.html">Publications</a>
			<ul>
			  <li><a href="../BSI/BSI-guidelines-2011.html">2011 Guidelines for the Prevention of Intravascular Catheter-Related Infections</a>
		        <ul>
		          <li><a href="../BSI/toc-BSI-guidelines-2011.html">Table of Contents</a></li>
		          <li><a href="../BSI/01-BSI-guidelines-2011.html">Notice to Readers</a> </li>
		          <li><a href="../BSI/02-bsi-summary-of-recommendations-2011.html">Summary Of Recommendations</a> </li>
		          <li><a href="../BSI/03-bsi-summary-of-recommendations-2011.html">Patient Cleansing 
		            </a></li>
		          <li><a href="../BSI/04-bsi-background-info-2011.html">Background Information</a></li>
		          <li><a href="../BSI/05-bsi-background-info-2011.html">Maximal Sterile Barrier Precautions 
		            </a></li>
		          <li><a href="../BSI/06-bsi-background-info-2011.html">Antibiotic Lock Prophylaxis, Antimicrobial Catheter Flush and Catheter Lock Prophylaxis 
		            </a></li>
		          <li><a href="../BSI/07-bsi-background-info-2011.htmles-2011.html">Replacement of Administration Sets</a></li>
		          <li><a href="../BSI/bsi-table-1-2011.html">Table 1. Catheters used for venous and arterial access</a></li>
		          <li><a href="../BSI/13-references-BSI-guidelines-2011.html">References</a></li>
		          <li><a href="../BSI/11-appendix-B-BSI-guidelines-2011.html">Appendix B. Disclosure of financial interests or relationships</a></li>
		          <li><a href="../BSI/12-appendix-C-BSI-guidelines-2011.html">Appendix C. Summary of Recommendations</a></li>
	            </ul>
			  </li>
		      <li><a href="../norovirus/002_norovirus-toc.html">2011 Norovirus Guidelines
		        </a>
		        <ul>
		          <li><a href="../norovirus/003_norovirus-abbreviations.html">Abbreviations</a></li>
					   
					   <li><a href="../norovirus/001_norovirus.html">Acknowledgement</a></li>
					   <li><a href="../norovirus/004_norovirus-exec-summary.html">Executive Summary</a></li>
					   <li><a href="../norovirus/005_norovirus-summaryOrecs.html">Summary of Recommendations</a></li>
					   <li><a href="../norovirus/006_norovirus-implement-audit.html">Implementation and Audit</a> </li>
					   <li> <a href="../norovirus/007_norovirus-recs-further-research.html">Recommendations for Further Research					     </a></li>
					   <li><a href="../norovirus/008_norovirus-background.html">Background					     </a></li>
					   <li><a href="../norovirus/009_norovirus-scope.html">Scope and Purpose</a> </li>
					   <li><a href="../norovirus/010_norovirus-methods.html">Methods</a> </li>
					   <li><a href="../norovirus/011_norovirus-evidence-review.html">Evidence Review Question 1</a>				       </li>
                       <li><a href="../norovirus/012_norovirus-evidence-q2.html">Question 2</a></li>
                       <li><a href="../norovirus/013_norovirus-evidence-q3.html">Question 3</a></li>
                  <li><a href="../norovirus/norovirus-appendix-1.html">Appendix 1</a></li>
                       <li><a href="../norovirus/norovirus-appendix-1b.html">Appendix 1B</a> </li>
                       <li><a href="../norovirus/tables/evidence-Table1.html">Evidence, Grade &amp; Study Quality Assessment Tables</a></li>
                  <li><a href="../norovirus/norovirus-appendix-3.html">Appendix 3</a></li>
                       <li><a href="../norovirus/norovirus-appendix-4.html">Appendix 4</a></li>
                       <li><a href="../norovirus/norovirus-references.html">References</a></li>
		        </ul>
		      </li>
	          <li><a href="acknowledg.html">2008 Disinfection &amp; Sterilization Guideline</a>               
	            <ul>
	              <li><a href="toc.html">Table of Contents</a></li>
	              <li><a href="1_sumIntroMethTerms.html">Executive Summary</a> </li>
	              <li><a href="2_approach.html">Approach to Disinfection and Sterilization</a> 
	                  <ul>
	                    <li><a href="3_0disinfectEquipment.html">Disinfection of Healthcare Equipment</a></li>
                        <li><a href="3_1deLaparoArthro.html">Laparoscopes and Arthroscopes</a> </li>
                        <li><a href="3_2contaminatedDevices.html">Disinfection of HBV, HCV, HIV or TB-Contaminated Devices</a></li>
                        <li><a href="3_3inactivBioAgents.html">Inactivation of Bioterrorist Agents</a></li>
                        <li><a href="3_4surfaceDisinfection.html">Surface Disinfection</a></li>
                    </ul>
	              </li>
                  <li><a href="4_0efficacyDS.html">Factors Affecting The Efficacy Of Disinfection And Sterilization</a></li>
                  <li><a href="5_0cleaning.html">Cleaning</a></li>
                  <li><a href="6_0disinfection.html">Disinfection</a>
                    <ul>
                      <li><a href="7_0formaldehyde.html">Formaldehyde</a></li>
                      <li><a href="8_0Iodophors.html">Iodophors</a></li>
                      <li><a href="9_0PceticAcidHydroPoxide.html">Peracetic Acid and Hydrogen Peroxide</a></li>
                    </ul>
                  </li>
                  <li><a href="10_0MiscAgents.html">Miscellaneous Inactivating Agents</a></li>
                  <li><a href="11_0regulatory_Framework.html">Regulatory Framework for Disinfectants and Sterilants</a></li>
                  <li><a href="13_0Sterilization.html">Sterilization</a>
                      <ul>
	                      
                        <li><a href="13_02sterilization.html">Low-Temperature Sterilization Technologies</a></li>
		                          
                        <li><a href="13_06PeraceticAcidSterilization.html">Peracetic Acid Sterilization</a></li>
		                         
                        <li><a href="13_10otherSterilizationMethods.html">Other Sterilization Methods</a></li>
                        <li><a href="13_11sterilizingPractices.html">Sterilizing Practices</a></li>
                    </ul>
                  </li>
                  <li><a href="14_00ReuseMedicalDevices.html">Reuse of Single-Use Medical Devices</a></li>
                  <li><a href="17_00Recommendations.html">Recommendations for Disinfection and Sterilization in Health-Care Facilities</a></li>
                  <li><a href="18_00PerformanceIndicators.html">Performance Indicators</a></li>
                  <li><a href="19_00glossary.html">Glossary</a></li>
                  <li><a href="table_1.html">Tables &amp; Figure</a>
                    <ul>
                      <li><a href="table_2.html">Table 2, 3</a></li>
                      <li><a href="fig_1.html">Figure 1</a></li>
                      <li><a href="table_4.html">Table 4</a></li>
                      <li><a href="table_5.html">Table 5</a></li>
                      <li><a href="table_6.html">Table 6</a></li>
                      <li><a href="table_7.html">Table 7, 8, 9</a></li>
                      <li><a href="table_10.html">Table 10, 11, 12</a></li>
                    </ul>
                  </li>
                  <li><a href="20_00reference.html">References</a></li>
                </ul>
              </li>
	          <li><a href="../2007IP/2007isolationPrecautions.html">Guideline for Isolation Precautions 2007</a>
				  <ul>
                        <li><a href="../2007IP/2007ip_ExecSummary.html">Executive Summary</a></li>
                        <li> <a href="../2007IP/2007ip_part1.html">Part I: Review of Scientific Data Regarding Transmission of Infectious Agents in Healthcare Settings</a></li>
                        <li><a href="../2007IP/2007ip_part2.html">Part II: Fundamental elements needed to prevent transmission of infectious agents in healthcare settings</a></li>
                        <li><a href="../2007IP/2007ip_part3.html">Part III: Precautions to Prevent Transmission of Infectious Agents</a></li>
                        <li><a href="../2007IP/2007ip_part4.html">Part IV: Recommendations</a></li>
                        <li><a href="../2007IP/2007ip_appendA.html">Appendix A</a></li>
                        <li><a href="../2007IP/2007ip_tables.html">Tables 1 - 5</a>
                          <ul>
                            <li><a href="../2007IP/2007ip_table2.html">Table 2</a></li>
                            <li><a href="../2007IP/2007ip_table3.html">Table 3</a></li>
                            <li><a href="../2007IP/2007ip_table4.html">Table 4</a></li>
                            <li><a href="../2007IP/2007ip_table5.html">Table 5</a></li>
                          </ul>
                        </li>
                        <li><a href="../2007IP/2007ip_fig.html">Figure. Example of Safe Donning and Removal of PPE</a></li>
                        <li><a href="../2007IP/2007ip_glossary.html">Glossary</a></li>
                        <li><a href="../2007IP/2007ip_reference.html">References</a></li>
                </ul>
			  </li>
			    
	            <li><a href="../cauti/001_cauti.html">2009 CAUTI Guideline</a>
	              <ul>
	                <li><a href="../cauti/002_cauti_toc.html">Table of Contents</a>
	                  <!--<ul><li><a href="/hicpac/Disinfection_Sterilization/1_sumIntroMethTerms-levi.html">test</a></li></ul>-->
                    </li>
                      <li><a href="../cauti/02_cauti2009_abbrev.html">Abbreviations</a></li>
                      <li><a href="../cauti/003_cauti2009_execSum.html">I. Executive Summary</a></li>
                      <li><a href="../cauti/002_cauti_sumORecom.html">II. Summary of Recommendations</a></li>
                      <li><a href="../cauti/003_ImplementAudit.html">III. Implementation and Audit</a></li>
                      <li><a href="../cauti/004_furtherResearch.html">IV. Recommendations for Further Research</a></li>
                      <li><a href="../cauti/005_background.html">V. Background</a></li>
                      <li><a href="../cauti/006_scopePurpose.html">VI. Scope and Purpose</a></li>
                      <li><a href="../cauti/007_methods.html">VII. Methods</a></li>
                      <li><a href="../cauti/008_evidenceReview.html">VIII. Evidence Review</a></li>
                      <li><a href="../cauti/009_cauti2009_References.html">References</a></li>
                      <li><a href="../cauti/010_cauti2009_figs.html">Figures</a></li>
		          </ul>
              </li>
              
              <li><a href="../CAUTI_fastFacts.html">CAUTI Guideline Fast Facts</a></li>
              <li><a href="../uti_saint_video.html">Podcast: Dr. Sanjay Saint discusses CAUTIs</a></li>
              <li><a href="../mdro/mdro_0.html">Management of MDRO's in Healthcare Settings</a>
	          <ul>
	            <li><a href="../mdro/mdro_toc.html">Table of Contents</a></li>
	            <li><a href="../mdro/mdro_1.html">Introduction</a></li>
	            <li><a href="../mdro/mdro_2.html">Background</a></li>
	            <li><a href="../mdro/mdro_3.html">Epidemiology of MDROs</a></li>
	            <li><a href="../mdro/mdro_4.html">MDRO Prevention and Control</a></li>
	            <li><a href="../mdro/mdro_4_1.html">Discussion</a></li>
	            <li><a href="../mdro/mdro_5.html">Prevention of transmission of Multidrug Resistant Organisms </a></li>
	            <li><a href="../mdro/mdro_table1.html">Tables 1-2</a></li>
	            <li><a href="../mdro/mdro_table3.html">Table 3</a> </li>
	            <li><a href="../mdro/mdro_glossary.html">Glossary - Multidrug-Resistant Organisms</a></li>
	            <li><a href="../mdro/mdro_reference.html">References</a></li>
              </ul>
	        </li>
	        <li><a href="../pubReportGuide/publicReportingHAI.html">Guidance on Public Reporting of HAIs 2003</a>
			      <ul>
			        <li><a href="../pubReportGuide/prg_tbl1.html">Table 1</a></li>
		            <li><a href="../pubReportGuide/prg_tbl2.html">Table 2</a></li>
                    <li><a href="../pubReportGuide/prHAI_reference.html">Reference</a></li>
	              </ul>
		      </li>
            <li><a href="../SSI/001_SSI.html">Guideline for Prevention of Surgical Site Infection, 1999 </a>
              <ul>
                <li><a href="../SSI/toc_SSI.html"> Table of contents</a></li>
                
                <li><a href="../SSI/002_SSI.html">Surgical Site Infection (SSI): An Overview</a></li>
                <li><a href="../SSI/003_SSI.html">Microbiology</a></li>
                <li><a href="../SSI/004_SSI.html"> Operative characteristics: Preoperative issues                                 </a></li>
                <li><a href="../SSI/005_SSI.html">Operative characteristics: Intraoperative issues 
                                 </a></li>
                <li><a href="../SSI/006_SSI.html">SSI Surveillance </a></li>
                <li><a href="../SSI/007_SSI.html">Recommendations for Prevention of SSI</a></li>
                <li><a href="../SSI/ref-SSI.html">References </a></li>
                <li><a href="../SSI/figure-SSI.html">Figure</a></li>
                <li><a href="../SSI/table1-SSI.html">Table 1</a></li>
                <li><a href="../SSI/table2-SSI.html">Table 2</a></li>
                <li><a href="../SSI/table3-SSI.html">Table 3</a></li>
                <li><a href="../SSI/table4-SSI.html">Table 4</a></li>
                <li><a href="../SSI/table5-SSI.html">Table 5</a></li>
                <li><a href="../SSI/table6-SSI.html">Table 6</a></li>
                <li><a href="../SSI/table7-8-9-10-SSI.html">Table 7-8-9-10</a></li>
              </ul>
            </li>
            <li><a href="../Pubs/Antibiotic-Stewardship-Statement.html">Antibiotic Stewardship Statement for Antibiotic Guidelines, 2016</a></li>
      </ul>
	  </li>
       
	<li><a href="../presentations.html">Proceedings &amp; Presentations</a>
	  <!--ul>
	    <li><a href="/hicpac/transcript-07-23.html">July 09 - Interim Guidance for Care of Patients with Confirmed /Suspected 2009 H1N1</a></li>
        <li><a href="/hicpac/h1n12009.html">Summary of Recommendations for Care of Patients with Confirmed /Suspected 2009 H1N1</a></li>
	  </ul-->
	</li>
   
    <!--li><a href="/hicpac/registration.html">HICPAC Online Registration</a></li-->
    <li><a href="../contact.html">Contact HICPAC</a></li>
  </ul>
</div>
<div class="bottom"></div>

				
				<!-- InstanceEndEditable -->
				</div>
				
				<!-- ########## BREADCRUMBS START HERE ########## -->
				<!-- InstanceBeginEditable name="breadcrumbs" -->
			<div id="breadBox">
	<ul id="breadcrumbs">
		<li style="display:none;"></li>
	</ul>
</div>
			<!-- InstanceEndEditable -->
				
				<div id="content-main">
					<div class="main-inner">
						
						<!-- InstanceBeginEditable name="content-main" -->
					 <h1>Guideline for Disinfection and Sterilization in Healthcare Facilities, 2008</h1>
					
                      
                       
  <div id="onthispage">
<div class="rounders grey bulleted-links">
<div class="inner">
<div class="t"></div>

<h4>On this Page</h4>
<div class="subc">
<ul>
<li><a href="8_0Iodophors.html#">Iodophors</a> </li>
 <li><a href="8_0Iodophors.html#a1">Ortho-phthalaldehyde</a> </li>
    <li><a href="8_0Iodophors.html#a2">Peracetic Acid</a></li>
    
    
    
</ul>
</div>
</div>

<div class="b">
<div></div>
</div>
</div>
</div>
	
     <p><a href="https://www.cdc.gov/hicpac/pdf/guidelines/Disinfection_Nov_2008.pdf" >Guideline for Disinfection and Sterilization in Healthcare Facilities, 2008 [PDF - 948 KB]</a></p>				
	
     
       

<h3>Iodophors</h3>

<p><strong><em>Overview</em></strong>. Iodine solutions or tinctures long have been used by health professionals primarily as antiseptics on skin or tissue. Iodophors, on the other hand, have been used both as antiseptics and disinfectants. FDA has not cleared any liquid chemical sterilant or high-level disinfectants with iodophors as the main active ingredient. An iodophor is a combination of iodine and a solubilizing agent or carrier; the resulting complex provides a sustained-release reservoir of iodine and releases small amounts of free iodine in aqueous solution. The best-known and most widely used iodophor is povidone-iodine, a compound of polyvinylpyrrolidone with iodine. This product and other iodophors retain the germicidal efficacy of iodine but unlike iodine generally are nonstaining and relatively free of toxicity and irritancy <sup>677, 678</sup>.</p>
<p>
Several reports that documented intrinsic microbial contamination of antiseptic formulations of povidone-iodine and poloxamer-iodine <sup>679-681</sup> caused a reappraisal of the chemistry and use of iodophors <sup>682</sup>. &quot;Free&quot; iodine (I2) contributes to the bactericidal activity of iodophors and dilutions of iodophors demonstrate more rapid bactericidal action than does a full-strength povidone-iodine solution. The reason for the observation that dilution increases bactericidal activity is unclear, but dilution of povidone-iodine might weaken the iodine linkage to the carrier polymer with an accompanying increase of free iodine in solution <sup>680</sup>. Therefore, iodophors must be diluted according to the manufacturers' directions to achieve antimicrobial activity.</p>


<p><strong><em>Mode of Action.</em></strong> Iodine can penetrate the cell wall of microorganisms quickly, and the lethal effects are believed to result from disruption of protein and nucleic acid structure and synthesis.</p>

<p><em><strong>Microbicidal Activity.</strong></em> Published reports on the in vitro antimicrobial efficacy of iodophors demonstrate that iodophors are bactericidal, mycobactericidal, and virucidal but can require prolonged contact times to kill certain fungi and bacterial spores <sup>14, 71-73, 290, 683-686</sup>. Three brands of povidone-iodine solution have demonstrated more rapid kill (seconds to minutes) of <em>S. aureus </em>and<em> M. chelonae</em> at a 1:100 dilution than did the stock solution <sup>683</sup>. The virucidal activity of 75&ndash;150 ppm available iodine was demonstrated against seven viruses <sup>72</sup>. Other investigators have questioned the efficacy of iodophors against poliovirus in the presence of organic matter 685and rotavirus SA-11 in distilled or tapwater <sup>290</sup>. Manufacturers' data demonstrate that commercial iodophors are not sporicidal, but they are tuberculocidal, fungicidal, virucidal, and bactericidal at their recommended use-dilution. </p>


<p><em><strong>Uses.</strong></em> Besides their use as an antiseptic, iodophors have been used for disinfecting blood culture bottles and medical equipment, such as hydrotherapy tanks, thermometers, and endoscopes. Antiseptic iodophors are not suitable for use as hard-surface disinfectants because of concentration differences. Iodophors formulated as antiseptics contain less free iodine than do those formulated as disinfectants <sup>376</sup>. Iodine or iodine-based antiseptics should not be used on silicone catheters because they can adversely affect the silicone tubing <sup>687</sup>.</p>

                 
                   
           
            <p class="topOPage"><a href="8_0Iodophors.html#">Top of Page</a></p> 
            <p><a name="a1" id="a1"></a></p>        
                    
            

<h3>Ortho-phthalaldehyde (OPA)</h3>

<p><strong><em>Overview</em></strong>.  Ortho-phthalaldehyde is a high-level disinfectant that received FDA clearance in October 1999. It contains 0.55% 1,2-benzenedicarboxaldehyde (OPA). OPA solution is a clear, pale-blue liquid with a pH of 7.5. (Tables 4 and 5)</p>



<p><strong><em>Mode of Action.</em></strong> Preliminary studies on the mode of action of OPA suggest that both OPA and glutaraldehyde interact with amino acids, proteins, and microorganisms. However, OPA is a less potent cross-linking agent. This is compensated for by the lipophilic aromatic nature of OPA that is likely to assist its uptake through the outer layers of mycobacteria and gram-negative bacteria <sup>688-690</sup>. OPA appears to kill spores by blocking the spore germination process 691.</p>

<p><em><strong>Microbicidal Activity.</strong></em> Studies have demonstrated excellent microbicidal activity in vitro <sup>69, 100, 271, 400, 692-703</sup>. For example, OPA has superior mycobactericidal activity (5-log<sub>10</sub> reduction in 5 minutes) to glutaraldehyde. The mean times required to produce a 6-log<sub>10 </sub>reduction for M. bovis using 0.21% OPA was 6 minutes, compared with 32 minutes using 1.5% glutaraldehyde 693. OPA showed good activity against the mycobacteria tested, including the glutaraldehyde-resistant strains, but 0.5% OPA was not sporicidal with 270 minutes of exposure. Increasing the pH from its unadjusted level (about 6.5) to pH 8 improved the sporicidal activity of OPA 694. The level of biocidal activity was directly related to the temperature. A greater than 5-log<sub>10</sub> reduction of B. atrophaeus spores was observed in 3 hours at 35ºC, than in 24 hours at 20ºC. Also, with an exposure time &lt;5 minutes, biocidal activity decreased with increasing serum concentration. However, efficacy did not differ when the exposure time was >10 minutes <sup>697</sup>. In addition, OPA is effective (>5-log10 reduction) against a wide range of microorganisms, including glutaraldehyde-resistant mycobacteria and B. atrophaeus spores <sup>694</sup>.</p>
<p>
The influence of laboratory adaptation of test strains, such as P. aeruginosa, to 0.55% OPA has been evaluated. Resistant and multiresistant strains increased substantially in susceptibility to OPA after laboratory adaptation (log<sub>10</sub> reduction factors increased by 0.54 and 0.91 for resistant and multiresistant strains, respectively) <sup>704</sup>. Other studies have found naturally occurring cells of P. aeurginosa were more resistant to a variety of disinfectants than were subcultured cells <sup>705</sup>. </p>


<p><em><strong>Uses.</strong></em> OPA has several potential advantages over glutaraldehyde. It has excellent stability over a wide pH range (pH 3&ndash;9), is not a known irritant to the eyes and nasal passages <sup>706</sup>, does not require exposure monitoring, has a barely perceptible odor, and requires no activation. OPA, like glutaraldehyde, has excellent material compatibility. A potential disadvantage of OPA is that it stains proteins gray (including unprotected skin) and thus must be handled with caution <sup>69</sup>. However, skin staining would indicate improper handling that requires additional training and/or personal protective equipment (e.g., gloves, eye and mouth protection, and fluid-resistant gowns). OPA residues remaining on inadequately water-rinsed transesophageal echo probes can stain the patient's mouth <sup>707</sup>. Meticulous cleaning, using the correct OPA exposure time (e.g., 12 minutes) and copious rinsing of the probe with water should eliminate this problem. The results of one study provided a basis for a recommendation that rinsing of instruments disinfected with OPA will require at least 250 mL of water per channel to reduce the chemical residue to a level that will not compromise patient or staff safety (&lt;1 ppm) <sup>708</sup>. Personal protective equipment should be worn when contaminated instruments, equipment, and chemicals are handled <sup>400</sup>. In addition, equipment must be thoroughly rinsed to prevent discoloration of a patient's skin or mucous membrane.
In April 2004, the manufacturer of OPA disseminated information to users about patients who reportedly experienced an anaphylaxis-like reaction after cystoscopy where the scope had been reprocessed using OPA. Of approximately 1 million urologic procedures performed using instruments reprocessed using OPA, 24 cases (17 cases in the United States, six in Japan, one in the United Kingdom) of anaphylaxis-like reactions have been reported after repeated cystoscopy (typically after four to nine treatments). Preventive measures include removal of OPA residues by thorough rinsing and not using OPA for reprocessing urologic instrumentation used to treat patients with a history of bladder cancer (Nevine Erian, personal communication, June 4, 2004; Product Notification, Advanced Sterilization Products, April 23, 2004) <sup>709</sup>.
A few OPA clinical studies are available. In a clinical-use study, OPA exposure of 100 endoscopes for 5 minutes resulted in a >5-log<sub>10</sub> reduction in bacterial load. Furthermore, OPA was effective over a 14-day use cycle 100. Manufacturer data show that OPA will last longer in an automatic endoscope reprocessor before reaching its MEC limit (MEC after 82 cycles) than will glutaraldehyde (MEC after 40 cycles) <sup>400</sup>. High-pressure liquid chromatography confirmed that OPA levels are maintained above 0.3% for at least 50 cycles <sup>706, 710</sup>. OPA must be disposed in accordance with local and state regulations. If OPA disposal through the sanitary sewer system is restricted, glycine (25 grams/gallon) can be used to neutralize the OPA and make it safe for disposal.</p>
<p>
The high-level disinfectant label claims for OPA solution at 20ºC vary worldwide (e.g., 5 minutes in Europe, Asia, and Latin America; 10 minutes in Canada and Australia; and 12 minutes in the United States). These label claims differ worldwide because of differences in the test methodology and requirements for licensure. In an automated endoscope reprocessor with an FDA-cleared capability to maintain solution temperatures at 25ºC, the contact time for OPA is 5 minutes.  </p>

                       
                        <p class="topOPage"><a href="8_0Iodophors.html#">Top of Page</a></p> 
                       
                       
                        <p><a name="a2" id="a2"></a></p>
                       

<h3>Peracetic Acid</h3>

<p><strong><em>Overview</em></strong>.  Peracetic, or peroxyacetic, acid is characterized by rapid action against all microorganisms. Special advantages of peracetic acid are that it lacks harmful decomposition products (i.e., acetic acid, water, oxygen, hydrogen peroxide), enhances removal of organic material <sup>711</sup>, and leaves no residue. It remains effective in the presence of organic matter and is sporicidal even at low temperatures (Tables 4 and 5). Peracetic acid can corrode copper, brass, bronze, plain steel, and galvanized iron but these effects can be reduced by additives and pH modifications. It is considered unstable, particularly when diluted; for example, a 1% solution loses half its strength through hydrolysis in 6 days, whereas 40% peracetic acid loses 1%&ndash;2% of its active ingredients per month <sup>654</sup>.</p>



<p><strong><em>Mode of Action.</em></strong> Little is known about the mechanism of action of peracetic acid, but it is believed to function similarly to other oxidizing agents—that is, it denatures proteins, disrupts the cell wall permeability, and oxidizes sulfhydryl and sulfur bonds in proteins, enzymes, and other metabolites <sup>654</sup>.</p>

<p><em><strong>Microbicidal Activity.</strong></em> Peracetic acid will inactivate gram-positive and gram-negative bacteria, fungi, and yeasts in &lt;5 minutes at &lt;100 ppm. In the presence of organic matter, 200&ndash;500 ppm is required. For viruses, the dosage range is wide (12&ndash;2250 ppm), with poliovirus inactivated in yeast extract in 15 minutes with 1,500&ndash;2,250 ppm. In one study, 3.5% peracetic acid was ineffective against HAV after 1-minute exposure using a carrier test <sup>58</sup>. Peracetic acid (0.26%) was effective (log<sub>10</sub> reduction factor >5) against all test strains of mycobacteria (<em>M. tuberculosis, M. avium-intracellulare, M. chelonae,</em> and <em>M. fortuitum</em>) within 20&ndash;30 minutes in the presence or absence of an organic load <sup>607, 712</sup>. With bacterial spores, 500&ndash;10,000 ppm (0.05%&ndash;1%) inactivates spores in 15 seconds to 30 minutes using a spore suspension test <sup>654, 659, 713-715</sup>.</p>


<p><em><strong>Uses.</strong></em> An automated machine using peracetic acid to chemically sterilize medical (e.g., endoscopes, arthroscopes), surgical, and dental instruments is used in the United States <sup>716-718</sup>. As previously noted, dental handpieces should be steam sterilized. The sterilant, 35% peracetic acid, is diluted to 0.2% with filtered water at 50ºC. Simulated-use trials have demonstrated excellent microbicidal activity <sup>111, 718-722</sup>, and three clinical trials have demonstrated both excellent microbial killing and no clinical failures leading to infection <sup>90, 723, 724</sup>. The high efficacy of the system was demonstrated in a comparison of the efficacies of the system with that of ethylene oxide. Only the peracetic acid system completely killed 6 log<sub>10</sub> of <em>M. chelonae, E. faecalis,</em> and<em> B. atrophaeus</em> spores with both an organic and inorganic challenge <sup>722</sup>. An investigation that compared the costs, performance, and maintenance of urologic endoscopic equipment processed by high-level disinfection (with glutaraldehyde) with those of the peracetic acid system reported no clinical differences between the two systems. However, the use of this system led to higher costs than the high-level disinfection, including costs for processing ($6.11 vs. $0.45 per cycle), purchasing and training ($24,845 vs. $16), installation ($5,800 vs. $0), and endoscope repairs ($6,037 vs. $445) 90. Furthermore, three clusters of infection using the peracetic acid automated endoscope reprocessor were linked to inadequately processed bronchoscopes when inappropriate channel connectors were used with the system 725. These clusters highlight the importance of training, proper model-specific endoscope connector systems, and quality-control procedures to ensure compliance with endoscope manufacturer recommendations and professional organization guidelines. An alternative high-level disinfectant available in the United Kingdom contains 0.35% peracetic acid. Although this product is rapidly effective against a broad range of microorganisms <sup>466, 726, 727</sup>, it tarnishes the metal of endoscopes and is unstable, resulting in only a 24-hour use life <sup>727</sup>. </p>


                    
                    <p class="topOPage"><a href="8_0Iodophors.html#">Top of Page</a></p>
                    
          
            
                       

           
                   
                  
           
                    
                    
                    
                    
                    
                    <div class="module rounders grey multiPage-horiz" id="tableOfContent">
<div class="inner">
<div class="t"></div>

<div class="hd">
                          <h4><span><a href="7_0formaldehyde.html">Previous Page</a></span> 
                          <span class="nextLink"><a href="9_0PceticAcidHydroPoxide.html">Next Page</a></span></h4>
              </div>
                        <div class="bd"><span><a href="toc.html">Table of Contents</a></span></div>
                     </div>

<div class="b">
<div></div>
</div>
</div>                     
                       
					<!-- InstanceEndEditable -->
					<!-- /end .main-inner --></div>
					
					<div id="linkPolicy">&nbsp;</div>
				<!-- /end #content-main--></div>
				
			<!-- /end #content-inner --></div>
			
			<!-- ########## RIGHT COLUMN STARTS HERE ########## -->
			<div id="content-secondary">
				<div class="pageOptions">
					<div class="pageOptions-inner">
						<!-- If you're seeing this, the text-sizer include is depricated and the server-side-include reference should be removed from all pages -->
						<ul id="services" class="services">
							<li class="print"><a href="javascript:window.print();" title="Print page.">Print page</a></li>
						</ul>
						<!-- InstanceBeginEditable name="local-options" -->
                        
                        <ul class="services top-divide">
						  <li class="pdf"><a class="noDecoration" href="https://www.cdc.gov/hicpac/pdf/Disinfection_Sterilization/Pages47_49Disinfection_Nov_2008.pdf" title="PDF – 98 KB">Download page</a></li>
					    </ul>
                        
					
					<!-- InstanceEndEditable -->
						<!-- InstanceBeginEditable name="languages" -->
					 
				<!-- InstanceEndEditable -->
					</div>
				</div>
				
				
				<!-- InstanceBeginEditable name="gov-delivery" -->
			
			<!-- InstanceEndEditable -->
				<!-- InstanceBeginEditable name="contact-info" -->
			<div id="contact-info">
	<h5>Contact Us:</h5>
	<ul class="noBullet">
		<li class="mail">Centers for Disease Control and Prevention<br />
		1600 Clifton Rd<br />
		Atlanta, GA 30333</li>
		<li class="phone">800-CDC-INFO<br />
		(800-232-4636)<br />
		TTY: (888) 232-6348</li>
		<li><a href="../../cdc-info/requestform.html">Contact CDC&ndash;INFO</a></li>
	</ul>
</div>
			<!-- InstanceEndEditable -->
				
			<!-- /end #content-secondary --></div>
			
		<!-- /end #content --></div>
		
		<div class="preFoot">
			<div id="plugin-legend">
			<h3>File Formats Help:</h3>
			<ul>
				<li class="plugin-pdf"><a href="../../Other/plugins/index.html#pdf"><img src="../../TemplatePackage/images/icon_pdf.gif" alt="Adobe PDF file" /></a></li>
				<li class="plugin-word"><a href="../../Other/plugins/index.html#doc"><img src="../../TemplatePackage/images/icon_word.gif" alt="Microsoft Word file" /></a></li>
				<li class="plugin-excel"><a href="../../Other/plugins/index.html#xls"><img src="../../TemplatePackage/images/icon_excel.gif" alt="Microsoft Excel file" /></a></li>
				<li class="plugin-ppt"><a href="../../Other/plugins/index.html#ppt"><img src="../../TemplatePackage/images/icon_ppt.gif" alt="Microsoft PowerPoint file" /></a></li>
				<li class="plugin-wmv"><a href="../../Other/plugins/index.html#wmv"><img src="../../TemplatePackage/images/icon_wmv.gif" alt="Audio/Video file" /></a></li>
				<li class="plugin-zip"><a href="../../Other/plugins/index.html#zip"><img src="../../TemplatePackage/images/icon_zip.gif" alt="Zip Archive file" /></a></li>
				<li class="plugin-real"><a href="../../Other/plugins/index.html#ram"><img src="../../TemplatePackage/images/icon_real.gif" alt="RealPlayer file" /></a></li>
				<li class="plugin-qt"><a href="../../Other/plugins/index.html#qt"><img src="../../TemplatePackage/images/icon_qt.gif" alt="Apple Quicktime file" /></a></li>
			</ul>
			<p><a href="../../Other/plugins/index.html"><span class="tp-label">How do I view different file formats (PDF, DOC, PPT, MPEG) on this site?</span>&nbsp;<img src="../../TemplatePackage/images/btn_dblArrows.gif" alt="double arrows." /></a></p>
		</div>
			<div class="pageOptions-horizontal">
				<ul class="services">
					<li class="print"><a href="javascript:window.print();">Print</a></li>

					<!-- InstanceBeginEditable name="local-options-horizontal" -->
				
				<!-- InstanceEndEditable -->
				</ul>
			</div>
			<div id="datestamp"><!-- InstanceBeginEditable name="date-stamp" -->
			<ul>
				<li class="last-reviewed">Page last reviewed: <span>December 29, 2009</span></li>
				<li class="last-updated">Page last updated: <span>December 29, 2009</span></li>
				 <li class="content-source">Content source: <a href="../../index.html">Centers for Disease Control and Prevention</a><br /> <a href="../../ncezid.1.html">National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)</a><br /> <a href="../../ncezid/dhqp/index.html">Division of Healthcare Quality Promotion (DHQP)</a></li>

			</ul>
		<!-- InstanceEndEditable -->
			</div>
		</div>
		
		<div id="siteinfo">
	<div id="siteinfo-nav">
		<ul class="menu">
			<li><a href="../../index.html">Home</a></li>
			<li><a href="../../az/a.html">A-Z Index</a></li>
			<li><a href="../../Other/policies.html">Policies</a></li>
			<li><a href="../../Other/about_cdcgov.html">Using this Site</a></li>
			<li><a href="../../Other/link.html">Link to Us</a></li>
			<li class="last-child"><a href="../../contact.1.html">Contact CDC</a></li>
		</ul>
	</div>
	<div id="siteinfo-credits">
		<div id="siteinfo-logos"><a href="https://www.usa.gov//"><img id="logo_usagov" src="../../TemplatePackage/images/logo_usagov.gif" alt="USA.gov: The U.S. Government's Official Web Portal" width="188" height="55" border="0" /></a><a href="https://www.hhs.gov/"><img id="logo_dhhs" src="../../TemplatePackage/images/logo_dhhs.gif" alt="Department of Health and Human Services" width="61" height="55" border="0" /></a></div>
		<address>Centers for Disease Control and Prevention &nbsp; 1600 Clifton Road Atlanta, GA 30329-4027, USA<br />
		800-CDC-INFO (800-232-4636)	TTY: (888) 232-6348 - <a href="https://wwwn.cdc.gov/dcs/RequestForm.aspx">Contact CDC&ndash;INFO</a></address>
	</div>
</div>

<!--include virtual="/TemplatePackage/3.0/includes/interstitialModal.html" -->
		
		<div id="AZlist-container"><a name="az"></a>
	<span>A-Z Index</span>
	<ol class="AZlist">
		<li><a href="../../az/a.html">A</a></li>
		<li><a href="../../az/b.html">B</a></li>
		<li><a href="../../az/c.html">C</a></li>
		<li><a href="../../az/d.html">D</a></li>
		<li><a href="../../az/e.html">E</a></li>
		<li><a href="../../az/f.html">F</a></li>
		<li><a href="../../az/g.html">G</a></li>
		<li><a href="../../az/h.html">H</a></li>
		<li><a href="../../az/i.html">I</a></li>
		<li><a href="../../az/j.html">J</a></li>
		<li><a href="../../az/k.html">K</a></li>
		<li><a href="../../az/l.html">L</a></li>
		<li><a href="../../az/m.html">M</a></li>
		<li><a href="../../az/n.html">N</a></li>
		<li><a href="../../az/o.html">O</a></li>
		<li><a href="../../az/p.html">P</a></li>
		<li><a href="../../az/q.html">Q</a></li>
		<li><a href="../../az/r.html">R</a></li>
		<li><a href="../../az/s.html">S</a></li>
		<li><a href="../../az/t.html">T</a></li>
		<li><a href="../../az/u.html">U</a></li>
		<li><a href="../../az/v.html">V</a></li>
		<li><a href="../../az/w.html">W</a></li>
		<li><a href="../../az/x.html">X</a></li>
		<li><a href="../../az/y.html">Y</a></li>
		<li><a href="../../az/z.html">Z</a></li>
		<li><a href="../../az/0.html">#</a></li>
	</ol>
</div>

	<!-- /end #wrapper-inner --></div>
	
<!-- /end #wrapper --></div>

<!-- xxxxxxxxxxxxxxxxxx METRICS code begins here xxxxxxxxxxxxxxxxxxxxxxxxxxx-->
<div id="metrics">

<!-- Begin Google DAP inclusion -->
<script type="text/javascript" id="_fed_an_ua_tag" src="../../JScript/metrics/google/Universal-Federated-Analytics-Min.js@agency=HHS&amp;subagency=CDC"></script>
<!-- End Google DAP inclusion -->

<!-- SiteCatalyst code version: H.21. -->
<script language="JavaScript" type="text/javascript" src="../../JScript/metrics/topic_levels.js"></script>
<script language="JavaScript" type="text/javascript" src="../../JScript/metrics/s_code_v21_cdcgov.js"></script>
<script language="JavaScript" type="text/javascript">

<!-- InstanceBeginEditable name="metrics" -->
s.pageName=document.title;
s.channel="HICPAC";

siteCatalyst.setLevel1("NCEZID"); 
siteCatalyst.setLevel2("DHQP"); 
siteCatalyst.setLevel3("Healthcare Infection Control Practices Advisory Committee"); 
<!-- InstanceEndEditable -->
s.prop2=window.location.href;
s.prop26=document.title;
s.prop30=document.title;
s.prop31=window.location.href;
s.prop46=window.location.href;
s.server=window.location.hostname;

// Update the level variables here.
updateVariables(s);

/************* DO NOT ALTER ANYTHING BELOW THIS LINE ! **************/
var s_code=s.t();if(s_code)document.write(s_code);//--></script>
<script language="JavaScript" type="text/javascript"><!--
if(navigator.appVersion.indexOf('MSIE')>=0)document.write(unescape('%3C')+'\!-'+'-');
//--></script><noscript><a href="http://www.omniture.com" title="Web Analytics"><img src="https://smtrics.cdc.gov/b/ss/cdcgov/1/H.21--NS/01/H.21--NS/0" height="1" width="1" border="0" alt="Web Analytics" /></a></noscript><!--/DO NOT REMOVE/-->
<!-- End SiteCatalyst code version: H.21. -->
<!-- Begin Template Package Custom Interactions -->
<script type="text/javascript" src="../../JScript/metrics/rd_custom_interactions.js"></script>
<!-- End Template Package Custom Interactions -->
<!-- Begin Template Package DigitalGov Search Support -->
<script type="text/javascript" src="../../JScript/rd_search.js"></script>
<!-- End Template Package DigitalGov Search Support -->
</div>
<!-- xxxxxxxxxxxxxxxxxx METRICS code ends here xxxxxxxxxxxxxxxxxxxxxxxxxxx-->



</body>
<!-- InstanceEnd --></html>
